Global Carrier Screening Market
Healthcare Services

Carrier Screening Market Size Projected To Increase From $3.67 Billion To $6.57 Billion During The Forecast Period

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Carrier Screening Market Growth From $3.67 Billion In 2026 To $6.57 Billion By 2030 At A CAGR Of 15.7%

The market for carrier screening has experienced significant expansion recently, projected to increase from $3.16 billion in 2025 to $3.68 billion in 2026, reflecting a compound annual growth rate of 16.3%. This robust growth trajectory in the historical period is largely a consequence of heightened public understanding of genetic conditions, a broader availability of prenatal and preconception screening options, improvements in DNA sequencing techniques, increased reliance on laboratory diagnostic methods, and enhanced accessibility to professional genetic counseling.

The carrier screening market is poised for substantial expansion over the coming years, projected to reach $6.57 billion by 2030, driven by a robust compound annual growth rate of 15.7%. This anticipated surge is fueled by several key factors, including a heightened demand for personalized medical approaches, escalating investments in genomic research endeavors, the broader implementation of population-based screening programs, the increasing application of artificial intelligence in genomic data analysis, and a greater emphasis on proactive healthcare strategies. During this forecast horizon, significant market developments are expected to unfold, such as a greater uptake of comprehensive carrier screening panels, the continued advancement and utilization of next-generation sequencing technologies, the growing incorporation of AI for deciphering genetic information, the wider accessibility of preventive genetic testing, and an intensified focus on screening for reproductive health.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7952&type=smp

Carrier Screening Market Industry Drivers: What Is Driving Revenue Growth?

The expansion of the carrier screening market is projected to be fueled by the growing elderly demographic. This segment, comprising older individuals, may increasingly turn to carrier screening services, particularly when considering parenthood at an advanced age. Such screening can offer valuable insights into potential genetic risks linked to later-life conception as part of preconception or prenatal care. Illustrating this demographic shift, the Office for the National Statistics in the UK reported that in 2024, the population aged 90 and above reached 625,000, a rise from 612,000 in mid-2023, signifying a 2.2% increase. Consequently, this escalating geriatric population is a significant driver for the carrier screening market’s advancement.

#Carrier Screening Market Segment Landscape And Growth Potential

The carrier screening market covered in this report is segmented –

1) By Type: Expanded Carrier Screening, Targeted Disease Carrier Screening

2) By Medical Condition: Pulmonary Conditions, Hematological Conditions, Neurological Conditions, Other Medical Conditions

3) By Technology: DNA Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies

4) By End User: Hospitals, Reference Laboratories, Physician Offices And Clinics, Other End Users

Subsegments:

1) By Expanded Carrier Screening: Next-Generation Sequencing (NGS) Panels, Comprehensive Carrier Screening Tests

2) By Targeted Disease Carrier Screening: Single Gene Tests, Disease-Specific Panels, Ethnic Or Population-Specific Screening Tests

#Carrier Screening Market Growth Trends: What Is Influencing The Future Outlook?

In the competitive landscape of the carrier screening sector, leading entities are prioritizing innovation through initiatives like the development of advanced carrier screening panels to solidify their market standing. These specialized panels consist of a compilation of genetic assessments designed to detect carriers of specific genetic disorder mutations, irrespective of whether the individual displays any health symptoms. As an illustration, in February of 2023, Fulgent Genetics, Inc., a prominent United States-based firm renowned for its expertise in genetic testing and diagnostic solutions, unveiled its new Beacon787 comprehensive carrier screening panel. This cutting-edge panel encompasses 787 genes associated with both autosomal recessive and X-linked disorders, incorporating all genes categorized by the American College of Medical Genetics and Genomics (ACMG) as Tier 3. The integration of these genes is consistent with the latest practical recommendations from the ACMG, which endorse thorough screening for all expectant mothers and individuals contemplating conception. Fulgent’s Beacon787 is strategically designed to offer a fair and inclusive screening method applicable across diverse ethnic groups, underscoring the company’s dedication to enhancing genetic testing capabilities for a wider spectrum of diseases and supporting well-informed family planning choices.

Carrier Screening Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the carrier screening market are Invitae Corporation, BGI Genomics Co. Ltd., Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., Illumina Inc., Laboratory Corporation of America Holdings, MedGenome Inc., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 Holdings Corporation, Thermo Fisher Scientific Inc., Associated Regional and University Pathologists Inc., GeneDx LLC, GenPath Consultants and Technologies Private Limited, Good Start Genetics Inc., NIPD Genetics Co. Pvt. Ltd., Pathway Genomics Corp., PerkinElmer Inc., PreventionGenetics LLC, Progenity Inc.

Access The Complete Carrier Screening Market Report:

https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

Carrier Screening Market Regional Outlook: Where Are The Largest Opportunities Located?

North Americawas the largest region in the carrier screening market in 2025. Asia-Pacificis expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model